Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain. [PDF]
Bujalance-Cabrera C +8 more
europepmc +1 more source
Remission of Eosinophilic Otitis Media With Tezepelumab
Diana Betancor +6 more
openaire +1 more source
The Use of Biological Therapies in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Current State of Knowledge. [PDF]
Wrona J +6 more
europepmc +1 more source
Targeting the Epithelial Alarmin Pathway with Tezepelumab in Highly Comorbid, Biologic-Experienced Severe Asthma: 52-Week Real-World Outcomes. [PDF]
González-Pérez R +5 more
europepmc +1 more source
Galectin-10 and Charcot-Leyden Crystals in Chronic Rhinosinusitis with Nasal Polyps: Pathogenetic Insights and Clinical Implications. [PDF]
Kamiński B +4 more
europepmc +1 more source
From FEV<sub>1</sub> to Small Airways: AMethodological Review of Lung Function Assessment in Biologic-Treated Asthma. [PDF]
Yang HL +5 more
europepmc +1 more source
Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP). [PDF]
Lupia C +9 more
europepmc +1 more source
Delphi Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP) on the management of severe asthma in children and adolescents. [PDF]
Miraglia Del Giudice M +6 more
europepmc +1 more source
Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine. [PDF]
Chen G +11 more
europepmc +1 more source
Prevalence of dysphagia and eosinophilic esophagitis in patients with inflammatory bowel disease or type 2 inflammation: a cross-sectional multicenter screening study. [PDF]
Bäuerle M +15 more
europepmc +1 more source

